Cargando…

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

AIMS: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. METHODS AND RESULTS: A literature search covering 2000–2017 was performed. The Panel critically...

Descripción completa

Detalles Bibliográficos
Autores principales: Mach, François, Ray, Kausik K, Wiklund, Olov, Corsini, Alberto, Catapano, Alberico L, Bruckert, Eric, De Backer, Guy, Hegele, Robert A, Hovingh, G Kees, Jacobson, Terry A, Krauss, Ronald M, Laufs, Ulrich, Leiter, Lawrence A, März, Winfried, Nordestgaard, Børge G, Raal, Frederick J, Roden, Michael, Santos, Raul D, Stein, Evan A, Stroes, Erik S, Thompson, Paul D, Tokgözoğlu, Lale, Vladutiu, Georgirene D, Gencer, Baris, Stock, Jane K, Ginsberg, Henry N, Chapman, M John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047411/
https://www.ncbi.nlm.nih.gov/pubmed/29718253
http://dx.doi.org/10.1093/eurheartj/ehy182
_version_ 1783339940508073984
author Mach, François
Ray, Kausik K
Wiklund, Olov
Corsini, Alberto
Catapano, Alberico L
Bruckert, Eric
De Backer, Guy
Hegele, Robert A
Hovingh, G Kees
Jacobson, Terry A
Krauss, Ronald M
Laufs, Ulrich
Leiter, Lawrence A
März, Winfried
Nordestgaard, Børge G
Raal, Frederick J
Roden, Michael
Santos, Raul D
Stein, Evan A
Stroes, Erik S
Thompson, Paul D
Tokgözoğlu, Lale
Vladutiu, Georgirene D
Gencer, Baris
Stock, Jane K
Ginsberg, Henry N
Chapman, M John
author_facet Mach, François
Ray, Kausik K
Wiklund, Olov
Corsini, Alberto
Catapano, Alberico L
Bruckert, Eric
De Backer, Guy
Hegele, Robert A
Hovingh, G Kees
Jacobson, Terry A
Krauss, Ronald M
Laufs, Ulrich
Leiter, Lawrence A
März, Winfried
Nordestgaard, Børge G
Raal, Frederick J
Roden, Michael
Santos, Raul D
Stein, Evan A
Stroes, Erik S
Thompson, Paul D
Tokgözoğlu, Lale
Vladutiu, Georgirene D
Gencer, Baris
Stock, Jane K
Ginsberg, Henry N
Chapman, M John
author_sort Mach, François
collection PubMed
description AIMS: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. METHODS AND RESULTS: A literature search covering 2000–2017 was performed. The Panel critically appraised the data and agreed by consensus on the categorization of reported adverse effects. Randomized controlled trials (RCTs) and genetic studies show that statin therapy is associated with a modest increase in the risk of new-onset diabetes mellitus (about one per thousand patient-years), generally defined by laboratory findings (glycated haemoglobin ≥6.5); this risk is significantly higher in the metabolic syndrome or prediabetes. Statin treatment does not adversely affect cognitive function, even at very low levels of low-density lipoprotein cholesterol and is not associated with clinically significant deterioration of renal function, or development of cataract. Transient increases in liver enzymes occur in 0.5–2% of patients taking statins but are not clinically relevant; idiosyncratic liver injury due to statins is very rare and causality difficult to prove. The evidence base does not support an increased risk of haemorrhagic stroke in individuals without cerebrovascular disease; a small increase in risk was suggested by the Stroke Prevention by Aggressive Reduction of Cholesterol Levels study in subjects with prior stroke but has not been confirmed in the substantive evidence base of RCTs, cohort studies and case–control studies. CONCLUSION: Long-term statin treatment is remarkably safe with a low risk of clinically relevant adverse effects as defined above; statin-associated muscle symptoms were discussed in a previous Consensus Statement. Importantly, the established cardiovascular benefits of statin therapy far outweigh the risk of adverse effects.
format Online
Article
Text
id pubmed-6047411
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-60474112018-07-19 Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract Mach, François Ray, Kausik K Wiklund, Olov Corsini, Alberto Catapano, Alberico L Bruckert, Eric De Backer, Guy Hegele, Robert A Hovingh, G Kees Jacobson, Terry A Krauss, Ronald M Laufs, Ulrich Leiter, Lawrence A März, Winfried Nordestgaard, Børge G Raal, Frederick J Roden, Michael Santos, Raul D Stein, Evan A Stroes, Erik S Thompson, Paul D Tokgözoğlu, Lale Vladutiu, Georgirene D Gencer, Baris Stock, Jane K Ginsberg, Henry N Chapman, M John Eur Heart J Clinical Review AIMS: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. METHODS AND RESULTS: A literature search covering 2000–2017 was performed. The Panel critically appraised the data and agreed by consensus on the categorization of reported adverse effects. Randomized controlled trials (RCTs) and genetic studies show that statin therapy is associated with a modest increase in the risk of new-onset diabetes mellitus (about one per thousand patient-years), generally defined by laboratory findings (glycated haemoglobin ≥6.5); this risk is significantly higher in the metabolic syndrome or prediabetes. Statin treatment does not adversely affect cognitive function, even at very low levels of low-density lipoprotein cholesterol and is not associated with clinically significant deterioration of renal function, or development of cataract. Transient increases in liver enzymes occur in 0.5–2% of patients taking statins but are not clinically relevant; idiosyncratic liver injury due to statins is very rare and causality difficult to prove. The evidence base does not support an increased risk of haemorrhagic stroke in individuals without cerebrovascular disease; a small increase in risk was suggested by the Stroke Prevention by Aggressive Reduction of Cholesterol Levels study in subjects with prior stroke but has not been confirmed in the substantive evidence base of RCTs, cohort studies and case–control studies. CONCLUSION: Long-term statin treatment is remarkably safe with a low risk of clinically relevant adverse effects as defined above; statin-associated muscle symptoms were discussed in a previous Consensus Statement. Importantly, the established cardiovascular benefits of statin therapy far outweigh the risk of adverse effects. Oxford University Press 2018-07-14 2018-04-27 /pmc/articles/PMC6047411/ /pubmed/29718253 http://dx.doi.org/10.1093/eurheartj/ehy182 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Review
Mach, François
Ray, Kausik K
Wiklund, Olov
Corsini, Alberto
Catapano, Alberico L
Bruckert, Eric
De Backer, Guy
Hegele, Robert A
Hovingh, G Kees
Jacobson, Terry A
Krauss, Ronald M
Laufs, Ulrich
Leiter, Lawrence A
März, Winfried
Nordestgaard, Børge G
Raal, Frederick J
Roden, Michael
Santos, Raul D
Stein, Evan A
Stroes, Erik S
Thompson, Paul D
Tokgözoğlu, Lale
Vladutiu, Georgirene D
Gencer, Baris
Stock, Jane K
Ginsberg, Henry N
Chapman, M John
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
title Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
title_full Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
title_fullStr Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
title_full_unstemmed Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
title_short Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
title_sort adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
topic Clinical Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047411/
https://www.ncbi.nlm.nih.gov/pubmed/29718253
http://dx.doi.org/10.1093/eurheartj/ehy182
work_keys_str_mv AT machfrancois adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT raykausikk adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT wiklundolov adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT corsinialberto adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT catapanoalbericol adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT bruckerteric adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT debackerguy adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT hegeleroberta adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT hovinghgkees adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT jacobsonterrya adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT kraussronaldm adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT laufsulrich adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT leiterlawrencea adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT marzwinfried adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT nordestgaardbørgeg adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT raalfrederickj adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT rodenmichael adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT santosrauld adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT steinevana adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT stroeseriks adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT thompsonpauld adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT tokgozoglulale adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT vladutiugeorgirened adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT gencerbaris adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT stockjanek adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT ginsberghenryn adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT chapmanmjohn adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract
AT adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract